- Increasing demand for safe and easy-to-use medication distribution devices and attempts by healthcare providers to reduce human error in drug delivery are the primary factors driving the growth of the industry
- Market Size - USD 20.52 Billion in 2019, Market Growth - CAGR of 10.3%, Market Trends - High demand from developing nations
VANCOUVER, B.C., Oct. 5, 2020 /PRNewswire/ -- The Global Cell Culture Market is forecast to reach USD 45.12 Billion by 2027, according to a new report by Emergen Research. Rising demand for monoclonal antibodies, the growing emphasis on customized therapies, and increasing support for cell-based studies are some of the reasons that are driving demand for the industry for cell culture. The ever-increasing knowledge related to the benefits of cell culture-based vaccines has spurred business demand. Accordingly, the increasing use of battery culture-based vaccines to manage diseases is driving market development. Growing knowledge among doctors and patients about the applications of monoclonal antibody therapies further contributes to market development. Some of the groundbreaking biological drugs on the market have been monoclonal antibodies that are starting to evolve for sanitation and to manage certain diseases.
The rising prevalence of chronic diseases has contributed to an improvement in cytological studies, cell biology, and related work contributing to the development of the demand for cell culture. Moreover, a rise in the number of cancer-related research projects and higher implementations of gene therapy are some of the factors expected to boost market demand over the coming years. However, some elements, such as the strong regulatory structure and the high level of quality established by market leaders, can hinder the overall growth of the market in the coming years. Furthermore, stringent regulations are expected to restrict business expansion.
Request free sample of this research report at: https://www.emergenresearch.com/request-sample/33
Key Highlights From The Report
- Based on the consumables, sera generated a revenue of USD 06.56 billion in 2019 and predicted to rise with a CAGR of 10.4% in the forecast period due to increasing demand for cropping in cytological research projects.
- The incubators segment is expected to grow with a CAGR of 10.5% in the forecast period, owing to the lower profit margins distinguished by cell culture goods and technical developments.
- The biopharmaceutical application is the major contributor to the Cell Culture Market. The biopharmaceutical application of the North American region is the major shareholder and held around 29.2% of the market share in the year 2019, owing to the predominant use of mammalian cell cultures in the manufacture of mammalian pharmaceuticals and the rising demand for non-conventional drugs produced as a consequence of the bio-production of proteomic ally and genetically enhanced drugs.
- North America dominated the market for Cell Culture in 2019. The region's consistent focus on cost-effective and innovative procedures adopted in the area is driving the market growth. The North American region held approximately 32.7% of the market, followed by the Asia Pacific, which contains around 31.4% market in the year 2019.
- Key participants include Thermo Fisher Scientific Inc., Cell Culture Company LLC, Sigma-Aldrich Co. LLC, Corning Incorporated, Dickinson & Company, VWR International LLC, BioSpherix Ltd., General Electric, Sartorius AG, and Merck KGaA, among others.
To get leading market solutions, visit the link below:
https://www.emergenresearch.com/industry-report/cell-culture-market
For the purpose of this report, Emergen Research has segmented the global Cell Culture Market on the basis of consumables, product, application, and region:
Consumables Outlook (Revenue, USD Billion; 2017-2027)
- Media
- Sera
- Reagents
Product Outlook (Revenue, USD Billion; 2017-2027)
- Culture Systems
- Incubators
- Centrifuges
- Pipetting Instruments
- Biosafety Equipment
- Cryostorage Equipment
Application Outlook (Revenue, USD Billion; 2017-2027)
- Biopharmaceuticals
- Cancer Research
- Vaccine Production
- Drug Development
- Gene Therapy
- Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S
- Canada
- Europe
- Germany
- U.K.
- France
- Benelux
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of MEA
Find more similar research insights by Emergen Research:
Breath Analyzers Market By Application (Alcohol, Drug abuse, Tuberculosis and Asthma detection, Others), By Technology (Fuel cell, Semiconductor Oxide Sensor, Infrared Spectroscopy, Chemical Crystal, Others) and By Regions Forecasts to 2027
Assistive Reproductive Technology Market By Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor, Egg/Embryo Banking), By Technology (In-Vitro Fertilization (IVF)), By End-Users, Forecasts to 2027
Rehabilitation Robotics Market By Type (Therapeutic, Exoskeleton, Assistive, Others), By Body Part (Lower Extremity, Upper extremity), By Therapy (Balance, Gait, Limb Mobility), By Application (Neurology, Orthopedics, Others), By Region Forecasts to 2027
Neuromorphic Processing Market By Application (Single, Image, Data Processing, Object Detection, Others), By End User (Consumer Electronics, Automotive, Healthcare, Military and Defense, Others) and By Regions Forecasts to 2027
Peritoneal Dialysis Market By Product (Peritoneal Dialysis Solution, Peritoneal Dialysis Set, Device, Catheter), By Type (CAPD, APD), By End-User (Home-Based Dialysis, Dialysis Center & Hospital Based Dialysis) and Regions Forecasts to 2027
Synthetic Blood Substitutes Market By Source, By Type (Hemoglobin-Based Oxygen Carriers (HBOCs), Perfluorocarbon (PFCs)), By Application (Cardiovascular Diseases, Anemia, Malignant Neoplasm, Injuries and Trauma, Neonatal Conditions, Maternal Conditions, Organ Transplant), By End-Use, Forecasts to 2027
About Emergen Research At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade. With market-leading insights and an in-depth understanding of leading and niche technologies, our solutions address the most pertinent questions for your business needs. A major technological shift has been witnessed towards creating a 'Circular Economy,' fuelled by factors, such as the increased adoption of bio-based materials, along with other methods for achieving carbon neutrality. We are conversant in technologies, viz., Artificial Intelligence (AI), Augmented Reality (AR), Virtual Reality (VR), Robotic Process Automation (RPA), Smart Manufacturing, Internet of Things (IoT), Big Data Analytics, Machine learning, Nanotechnology, Edge Computing, Blockchain Technology, Cloud Computing, Vehicle Electrification, Advanced Maintenance Analytics, and Predictive Maintenance, among other prevalent and emergent technologies.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Read full Press Release at: https://www.emergenresearch.com/press-release/global-cell-culture-market
Logo: https://mma.prnewswire.com/media/1252126/Emergen_Research_Logo.jpg
